These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 7712726)

  • 1. Amyloidosis in patients with end-stage renal failure: uraemia associated or dialysis related?
    Davison AM
    Contrib Nephrol; 1995; 113():92-100. PubMed ID: 7712726
    [No Abstract]   [Full Text] [Related]  

  • 2. [Beta 2-microglobulin--its role in renal failure and hemodialysis therapy].
    Czyz W; Szepietowski T
    Postepy Hig Med Dosw; 1992; 46(2):209-38. PubMed ID: 1470582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First clinical experience with an adjunctive hemoperfusion device designed specifically to remove beta(2)-microglobulin in hemodialysis.
    Ronco C; Brendolan A; Winchester JF; Golds E; Clemmer J; Polaschegg HD; Muller TE; La Greca G ; Levin NW
    Blood Purif; 2001; 19(2):260-3. PubMed ID: 11150821
    [No Abstract]   [Full Text] [Related]  

  • 4. Pathogenetic and diagnostic aspects of dialysis-related amyloidosis.
    Schaeffer J; Floege J; Ehlerding G; Koch KM
    Nephrol Dial Transplant; 1995; 10 Suppl 3():4-8. PubMed ID: 7494614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta 2-microglobulin-related amyloidosis in patients receiving chronic hemodialysis.
    Gejyo F; Homma N; Maruyama H; Arakawa M
    Contrib Nephrol; 1988; 68():263-9. PubMed ID: 3069321
    [No Abstract]   [Full Text] [Related]  

  • 6. beta 2-microglobulin and amyloidosis: who is at risk?
    Davison AM
    Nephrol Dial Transplant; 1995; 10 Suppl 10():48-51. PubMed ID: 8825433
    [No Abstract]   [Full Text] [Related]  

  • 7. Beta-2 microglobulin in ESRD: an in-depth review.
    Winchester JF; Salsberg JA; Levin NW
    Adv Ren Replace Ther; 2003 Oct; 10(4):279-309. PubMed ID: 14681859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dialysis-related amyloidosis and acquired renal cystic disease with renal cell carcinoma in uremia.
    Wu TH; Tsai CY; Chiang SS; Wang JS; Huang TP; Yu CL
    Nephron; 1994; 67(1):129. PubMed ID: 7993425
    [No Abstract]   [Full Text] [Related]  

  • 9. Dialysis-related amyloidosis: an important cause of gastrointestinal symptoms in patients with end-stage renal disease.
    Mogyorosi A; Schubert ML
    Gastroenterology; 1999 Jan; 116(1):217-20. PubMed ID: 9869623
    [No Abstract]   [Full Text] [Related]  

  • 10. Dialysis amyloidosis.
    Lancet; 1991 Aug; 338(8763):349-50. PubMed ID: 1677703
    [No Abstract]   [Full Text] [Related]  

  • 11. [Amyloidosis of the dialysis patient].
    van Ypersele de Strihou C
    Bull Mem Acad R Med Belg; 1988; 143(10-12):456-65; discussion 465-7. PubMed ID: 3077074
    [No Abstract]   [Full Text] [Related]  

  • 12. Dialysis-related amyloidosis.
    Koch KM
    Kidney Int; 1992 May; 41(5):1416-29. PubMed ID: 1614057
    [No Abstract]   [Full Text] [Related]  

  • 13. Beta-2-microglobulin amyloidosis and osteo-articular pathology of the uremic patient on regular dialysis.
    Brancaccio D; Anelli A; Gallieni M; Padovese P; Coggi G; Uslenghi C
    Contrib Nephrol; 1990; 77():177-86. PubMed ID: 2188786
    [No Abstract]   [Full Text] [Related]  

  • 14. Beta 2-microglobulin amyloidosis in renal failure: understanding this recently recognized condition.
    Kay J
    Cleve Clin J Med; 1999 Mar; 66(3):145-7. PubMed ID: 10079583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pathogenesis of dialysis amyloidosis].
    Gejyo F; Hasegawa S; Homma N; Maruyama H; Maruyama S; Arakawa M
    Nihon Rinsho; 1992 Jan; 50 Suppl():796-800. PubMed ID: 1578769
    [No Abstract]   [Full Text] [Related]  

  • 16. Hemofiltration and the middle molecule.
    Henderson LW
    Blood Purif; 1999; 17(4):175-7. PubMed ID: 10494018
    [No Abstract]   [Full Text] [Related]  

  • 17. [Chronic renal failure: present and future. Pathophysiology and metabolic abnormalities--uremic toxin, middle and large molecular substances].
    Gejyo F
    Nihon Naika Gakkai Zasshi; 1986 Nov; 75(11):1550-4. PubMed ID: 3546560
    [No Abstract]   [Full Text] [Related]  

  • 18. [Changes in the picture of chronic diseases on long-term hemodialysis treatment].
    von Appen K; Ivanovich P; Klinkmann H; Stetsiuk E
    Urol Nefrol (Mosk); 1995; (5):25-7. PubMed ID: 8571479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenesis and management of dialysis-related amyloid bone disease.
    Nangaku M; Miyata T; Kurokawa K
    Am J Med Sci; 1999 Jun; 317(6):410-5. PubMed ID: 10372842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Amyloidosis in hemodialysis patients].
    Bardin T; Zingraff J; Benoît J; Kuntz D; Drüeke T
    Presse Med; 1987 May; 16(18):907-10. PubMed ID: 2954121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.